---
figid: PMC5642638__oncotarget-08-71317-g002
figlink: /pmc/articles/PMC5642638/figure/F2/
number: F2
caption: 'Androgen receptor (AR) activation induces PLZF expression, while PLZF acts
  as a negative feedback regulator of AR. In addition, PLZF represses mTORC1 signaling
  by upregulating REDD1 expression and RAS/RAF/MEK signaling through increasing related
  gene expression. PLZF can also prevent the formation of PBX1-HOX heterodimers. Activation
  of PI3K-AKT pathway inhibits FOXO3 which normally activates PLZF expression. Highly
  prostate enriched protein KLK4 whose expression is androgen dependent, is a key
  regulator of PLZF: it physically interacts with and inhibits PLZF inhibited pathways,
  resulting in tumor growth.'
pmcid: PMC5642638
papertitle: Role of PLZF as a tumor suppressor in prostate cancer.
reftext: Yang Jin, et al. Oncotarget. 2017 Sep 19;8(41):71317-71324.
pmc_ranked_result_index: '3646'
pathway_score: 0.9607968
filename: oncotarget-08-71317-g002.jpg
figtitle: Role of PLZF as a tumor suppressor in prostate cancer
year: '2017'
organisms:
- Homo sapiens
ndex: ca38a567-dedd-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5642638__oncotarget-08-71317-g002.html
  '@type': Dataset
  description: 'Androgen receptor (AR) activation induces PLZF expression, while PLZF
    acts as a negative feedback regulator of AR. In addition, PLZF represses mTORC1
    signaling by upregulating REDD1 expression and RAS/RAF/MEK signaling through increasing
    related gene expression. PLZF can also prevent the formation of PBX1-HOX heterodimers.
    Activation of PI3K-AKT pathway inhibits FOXO3 which normally activates PLZF expression.
    Highly prostate enriched protein KLK4 whose expression is androgen dependent,
    is a key regulator of PLZF: it physically interacts with and inhibits PLZF inhibited
    pathways, resulting in tumor growth.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK3
  - KLK4
  - KRAS
  - MAPK14
  - PBX1
  - FOXO3
  - MAPK1
  - MAP2K1
  - AKT1
  - PIK3R6
  - RPTOR
  - AR
  - BRAF
  - EGF
  - AKT3
  - MAPK8
  - MAPK11
  - MTOR
  - MAPK12
  - MAPK13
  - PIK3CG
  - PIK3R5
  - MAPK9
  - PIK3R4
  - DDIT4
  - MAP2K2
  - PIK3CA
  - AKT2
  - MAPK10
  - PIK3R3
  - PIK3CB
  - PIK3CD
  - ZBTB16
  - Androgen
  - Androgens
  - Cancer
genes:
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: (KLK4
  symbol: KLK4
  source: hgnc_symbol
  hgnc_symbol: KLK4
  entrez: '9622'
- word: KRAS
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PBX1
  symbol: PBX1
  source: hgnc_symbol
  hgnc_symbol: PBX1
  entrez: '5087'
- word: FOXO3
  symbol: FOXO3
  source: hgnc_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: AKT)
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: AKT)
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: REDD1
  symbol: REDD-1
  source: hgnc_alias_symbol
  hgnc_symbol: DDIT4
  entrez: '54541'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: AKT)
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PLZF
  symbol: PLZF
  source: hgnc_alias_symbol
  hgnc_symbol: ZBTB16
  entrez: '7704'
chemicals:
- word: Androgen
  source: MESH
  identifier: D000728
- word: Androgens
  source: MESH
  identifier: D000728
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC5642638__F2
redirect_from: /figures/PMC5642638__F2
figtype: Figure
---
